Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. Quick Links Corporate Presentation Responsibility News Portfolio Responsibility Report Annual Reports Leadership Governance SEC Filings Latest Press Releases January 24, 2023 Incyte to Present at Upcoming Investor Conference January 17, 2023 Incyte to Report Fourth Quarter and Year-End 2022 Financial Results December 15, 2022 Incyte to Present at Upcoming Investor Conferences All press releases Latest Events Feb 8 2023 Feb 8 2023 Guggenheim Healthcare Talks I Oncology Conference Click here for Webcast Feb 7 2023 Feb 7 2023 Q4/YE 2022 Incyte Corporation Earnings Conference Call Click here for Webcast All events
